Skip to content

Needling technique with topical Latanoprost in treatment of hypopigmented burn scars

Investigating the effectiveness of needling technique with topical Latanoprost in treatment of hypopigmented burn scars in burn patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20111123008177N18
Enrollment
30
Registered
2018-09-18
Start date
2018-09-23
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypopigmented scar. Other disorders of diminished melanin formation

Interventions

Intervention 1: Intervention group 1: Needling procedure is performed under local anesthesia on the hypopigmented or depigmated organs of the patient, measuring from 4 to 25 cm square. The German AMIE

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients aged 15-50 years. In two symmetrical regions of the body (focusing on the organs) having hypopigmented scars. Willing to cooperate and follow-up on treatment and complete the informed consent form.

Exclusion criteria

Exclusion criteria: Patients who are pregnant, are planning to become pregnant, or are breastfeeding. Those who have had severe systemic diseases in the past 6 months. Concomitant diseases (diabetes, connective tissue disease, chronic kidney disease, cardiovascular disease) and any type of disease that can cause immune system dysfunction and delay wound healing. Immunosuppressant drugs and corticosteroids. History of the use of depigmented or pigmented products on scars during the past 3 months. Have a history of allergy or high sensitivity to the compounds used in the study. Smoking and alcohol consumption. Since the onset of a lesion leading to hypopigmented or depigmented scars, only 6 months have passed.

Design outcomes

Primary

MeasureTime frame
Scar. Timepoint: Before intervention, 3 and 6 months after using the last dose of drops. Method of measurement: 0-4 scale (including resizing and colorimetric staining) and Vancouver Scar scale.

Secondary

MeasureTime frame
Patient satisfaction. Timepoint: Before intervention, 3 and 6 months after using the last dose of drops. Method of measurement: Visual Analog Scale.;Cost. Timepoint: The end of the study. Method of measurement: Estimated cost of microneedling process and latanoprost drops.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahnoush Momeni

Iran University of Medical Sciences

mah_momeni@yahoo.com+98 21 8888 4275

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026